Expression and characterization of PGD2 receptors in chronic rhinosinusitis: Modulation of DP and CRTH2 by PGD2

Miki Yamamoto, Mitsuhiro Okano, Tazuko Fujiwara, Shin Kariya, Takaya Higaki, Hitoshi Nagatsuka, Hidetsugu Tsujigiwa, Masao Yamada, Tadashi Yoshino, Yoshihiro Urade, Kazunori Nishizaki

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Background: Prostaglandin D2 (PGD2) participates in airway inflammation. We reported that levels of hematopoietic-type PGD 2 synthase (h-PGDS) in sinonasal tissues may play an important role in the pathophysiology of chronic rhinosinusitis (CRS). Two PGD2 receptors have been isolated, DP and CRTH2, but whether they participate in CRS remains unclear. We sought to determine the expression and characterization of DP and CRTH2 in CRS. Methods: Expression of DP and CRTH2 in nasal polyps (NP) and uncinate process mucosae (UPM) was examined by in situ hybridization and immunohistochemistry and evaluated by real-time quantitative PCR. h-PGDS, IL-5, eotaxin and RANTES expression was also determined. In addition, the effect of PGD2 on the expression of both receptors in UPM was assessed. Results: DP was widely expressed, not only in infiltrating inflammatory cells but also in constitutive cells such as vascular endothelial cells and ciliated columnar epithelia. CRTH2 was selectively expressed in inflammatory cells and some glands. Significantly greater levels of DP mRNA and conversely decreased levels of CRTH2 mRNA were observed in NP compared with UPM. DP and CRTH2 mRNA levels were not only positively and inversely correlated with levels of h-PGDS but also with eotaxin, respectively. Furthermore, addition of PGD2 significantly increased DP expression and conversely reduced CRTH2 expression in UPM. Conclusions: These results suggest that distinct expression of DP and CRTH2 is associated with the pathophysiology of CRS, including NP formation, and the expression of these receptors may be regulated by h-PGDS and PGD 2.

Original languageEnglish
Pages (from-to)127-136
Number of pages10
JournalInternational Archives of Allergy and Immunology
Volume148
Issue number2
DOIs
Publication statusPublished - Jan 2009

Fingerprint

prostaglandin R2 D-isomerase
Prostaglandin D2
Nasal Polyps
Mucous Membrane
Messenger RNA
Prostaglandins D
Chemokine CCL5
Interleukin-5
In Situ Hybridization
Real-Time Polymerase Chain Reaction
Epithelium
Endothelial Cells
Immunohistochemistry
Inflammation
prostaglandin D2 receptor

Keywords

  • Asthma
  • Chronic rhinosinusitis
  • CRTH1
  • DP
  • Nasal polyps
  • PGD
  • Synthase

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Expression and characterization of PGD2 receptors in chronic rhinosinusitis : Modulation of DP and CRTH2 by PGD2. / Yamamoto, Miki; Okano, Mitsuhiro; Fujiwara, Tazuko; Kariya, Shin; Higaki, Takaya; Nagatsuka, Hitoshi; Tsujigiwa, Hidetsugu; Yamada, Masao; Yoshino, Tadashi; Urade, Yoshihiro; Nishizaki, Kazunori.

In: International Archives of Allergy and Immunology, Vol. 148, No. 2, 01.2009, p. 127-136.

Research output: Contribution to journalArticle

@article{3ca99078f0034daf8f19279acd1db82d,
title = "Expression and characterization of PGD2 receptors in chronic rhinosinusitis: Modulation of DP and CRTH2 by PGD2",
abstract = "Background: Prostaglandin D2 (PGD2) participates in airway inflammation. We reported that levels of hematopoietic-type PGD 2 synthase (h-PGDS) in sinonasal tissues may play an important role in the pathophysiology of chronic rhinosinusitis (CRS). Two PGD2 receptors have been isolated, DP and CRTH2, but whether they participate in CRS remains unclear. We sought to determine the expression and characterization of DP and CRTH2 in CRS. Methods: Expression of DP and CRTH2 in nasal polyps (NP) and uncinate process mucosae (UPM) was examined by in situ hybridization and immunohistochemistry and evaluated by real-time quantitative PCR. h-PGDS, IL-5, eotaxin and RANTES expression was also determined. In addition, the effect of PGD2 on the expression of both receptors in UPM was assessed. Results: DP was widely expressed, not only in infiltrating inflammatory cells but also in constitutive cells such as vascular endothelial cells and ciliated columnar epithelia. CRTH2 was selectively expressed in inflammatory cells and some glands. Significantly greater levels of DP mRNA and conversely decreased levels of CRTH2 mRNA were observed in NP compared with UPM. DP and CRTH2 mRNA levels were not only positively and inversely correlated with levels of h-PGDS but also with eotaxin, respectively. Furthermore, addition of PGD2 significantly increased DP expression and conversely reduced CRTH2 expression in UPM. Conclusions: These results suggest that distinct expression of DP and CRTH2 is associated with the pathophysiology of CRS, including NP formation, and the expression of these receptors may be regulated by h-PGDS and PGD 2.",
keywords = "Asthma, Chronic rhinosinusitis, CRTH1, DP, Nasal polyps, PGD, Synthase",
author = "Miki Yamamoto and Mitsuhiro Okano and Tazuko Fujiwara and Shin Kariya and Takaya Higaki and Hitoshi Nagatsuka and Hidetsugu Tsujigiwa and Masao Yamada and Tadashi Yoshino and Yoshihiro Urade and Kazunori Nishizaki",
year = "2009",
month = "1",
doi = "10.1159/000155743",
language = "English",
volume = "148",
pages = "127--136",
journal = "International Archives of Allergy and Immunology",
issn = "1018-2438",
publisher = "S. Karger AG",
number = "2",

}

TY - JOUR

T1 - Expression and characterization of PGD2 receptors in chronic rhinosinusitis

T2 - Modulation of DP and CRTH2 by PGD2

AU - Yamamoto, Miki

AU - Okano, Mitsuhiro

AU - Fujiwara, Tazuko

AU - Kariya, Shin

AU - Higaki, Takaya

AU - Nagatsuka, Hitoshi

AU - Tsujigiwa, Hidetsugu

AU - Yamada, Masao

AU - Yoshino, Tadashi

AU - Urade, Yoshihiro

AU - Nishizaki, Kazunori

PY - 2009/1

Y1 - 2009/1

N2 - Background: Prostaglandin D2 (PGD2) participates in airway inflammation. We reported that levels of hematopoietic-type PGD 2 synthase (h-PGDS) in sinonasal tissues may play an important role in the pathophysiology of chronic rhinosinusitis (CRS). Two PGD2 receptors have been isolated, DP and CRTH2, but whether they participate in CRS remains unclear. We sought to determine the expression and characterization of DP and CRTH2 in CRS. Methods: Expression of DP and CRTH2 in nasal polyps (NP) and uncinate process mucosae (UPM) was examined by in situ hybridization and immunohistochemistry and evaluated by real-time quantitative PCR. h-PGDS, IL-5, eotaxin and RANTES expression was also determined. In addition, the effect of PGD2 on the expression of both receptors in UPM was assessed. Results: DP was widely expressed, not only in infiltrating inflammatory cells but also in constitutive cells such as vascular endothelial cells and ciliated columnar epithelia. CRTH2 was selectively expressed in inflammatory cells and some glands. Significantly greater levels of DP mRNA and conversely decreased levels of CRTH2 mRNA were observed in NP compared with UPM. DP and CRTH2 mRNA levels were not only positively and inversely correlated with levels of h-PGDS but also with eotaxin, respectively. Furthermore, addition of PGD2 significantly increased DP expression and conversely reduced CRTH2 expression in UPM. Conclusions: These results suggest that distinct expression of DP and CRTH2 is associated with the pathophysiology of CRS, including NP formation, and the expression of these receptors may be regulated by h-PGDS and PGD 2.

AB - Background: Prostaglandin D2 (PGD2) participates in airway inflammation. We reported that levels of hematopoietic-type PGD 2 synthase (h-PGDS) in sinonasal tissues may play an important role in the pathophysiology of chronic rhinosinusitis (CRS). Two PGD2 receptors have been isolated, DP and CRTH2, but whether they participate in CRS remains unclear. We sought to determine the expression and characterization of DP and CRTH2 in CRS. Methods: Expression of DP and CRTH2 in nasal polyps (NP) and uncinate process mucosae (UPM) was examined by in situ hybridization and immunohistochemistry and evaluated by real-time quantitative PCR. h-PGDS, IL-5, eotaxin and RANTES expression was also determined. In addition, the effect of PGD2 on the expression of both receptors in UPM was assessed. Results: DP was widely expressed, not only in infiltrating inflammatory cells but also in constitutive cells such as vascular endothelial cells and ciliated columnar epithelia. CRTH2 was selectively expressed in inflammatory cells and some glands. Significantly greater levels of DP mRNA and conversely decreased levels of CRTH2 mRNA were observed in NP compared with UPM. DP and CRTH2 mRNA levels were not only positively and inversely correlated with levels of h-PGDS but also with eotaxin, respectively. Furthermore, addition of PGD2 significantly increased DP expression and conversely reduced CRTH2 expression in UPM. Conclusions: These results suggest that distinct expression of DP and CRTH2 is associated with the pathophysiology of CRS, including NP formation, and the expression of these receptors may be regulated by h-PGDS and PGD 2.

KW - Asthma

KW - Chronic rhinosinusitis

KW - CRTH1

KW - DP

KW - Nasal polyps

KW - PGD

KW - Synthase

UR - http://www.scopus.com/inward/record.url?scp=51849118062&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=51849118062&partnerID=8YFLogxK

U2 - 10.1159/000155743

DO - 10.1159/000155743

M3 - Article

C2 - 18802357

AN - SCOPUS:51849118062

VL - 148

SP - 127

EP - 136

JO - International Archives of Allergy and Immunology

JF - International Archives of Allergy and Immunology

SN - 1018-2438

IS - 2

ER -